Identification of Rare and Novel PHEX Variants in X-linked Hypophosphatemia
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgae299 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Xiaosen Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical S…. Hauptthemen laut MEDLINE: Familial Hypophosphatemic Rickets, PHEX Phosphate Regulating Neutral Endopeptidase, Pedigree, Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology, Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
Context
X-linked hypophosphatemia (XLH) is a rare metabolic bone disease caused by inactivation mutations in the PHEX gene. Despite the extensive number of reported PHEX variants, only a few cases of chromosomal abnormalities have been documented.
Objective
We aimed to identify the pathogenic variants in 6 unrelated families with a clinical diagnosis of XLH and to propose a genetic workflow for hypophosphatemia patients suspected of having XLH.
Methods
Multiple genetic testing assays were used to analyze the 6 families' genetic profiles, including whole exome sequencing, multiplex ligation-dependent probe amplification, whole genome sequencing, reverse transcript polymerase chain reaction, Sanger sequencing, and karyotyping.
Results
The study identified 6 novel pathogenic variants, including 1 mosaic variant (exon 16-22 deletion), 3 chromosomal abnormalities (46, XN, inv[X][pter→p22.11::q21.31→p22.11::q21.31 →qter], 46, XN, inv[X][p22.11p22.11], and XXY), a nonclassical intron variant (NM_000444.6, c.1701_31A > G), and a deletion variant (NM_000444.6, c.64_5464-186 del5215) of PHEX. Additionally, a genetic testing workflow was proposed to aid in diagnosing patients suspected of XLH.
Conclusion
Our research expands the mutation spectrum of PHEX and highlights the significance of using multiple genetic testing methods to diagnose XLH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
- Medical Research Center, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
ORCID-Profile: Yiyi Gong, Yan Jiang, Ou Wang, Mei Li, Weibo Xia
Förderung
- National Natural Science Foundation of China
- Ministry of Science and Technology
- Chinese Academy of Medical Sciences
Zitieren
APA
Ma, X., Pang, Q., Gong, Y., Li, X., Liu, W., Jiang, Y., Wang, O., Li, M., Xing, X., & Xia, W. (2024). Identification of Rare and Novel PHEX Variants in X-linked Hypophosphatemia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae299
Vancouver
Ma X, Pang Q, Gong Y, Li X, Liu W, Jiang Y, et al. Identification of Rare and Novel PHEX Variants in X-linked Hypophosphatemia. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae299
BibTeX
@article{Ma2024,
author = {Ma, Xiaosen and Pang, Qianqian and Gong, Yiyi and Li, Xiang and Liu, Wei and Jiang, Yan and Wang, Ou and Li, Mei and Xing, Xiaoping and Xia, Weibo},
title = {Identification of Rare and Novel PHEX Variants in X-linked Hypophosphatemia},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgae299}
}
EUVIMED